Basal Cell Carcinomas in Gorlin Syndrome: A Review of 202 Patients. (7th September 2010)

• Record Type: Journal Article
• Authors: Jones, Elizabeth A.; Sajid, Mohammed Imran; Shenton, Andrew; Evans, D. Gareth
• Other Names: Kimyai-Asadi Arash Academic Editor.
• Is Part Of: Journal of skin cancer. Volume 2011(2011)
• Publication Date: 2010-09-07
• Subjects: Skin -- Cancer -- Periodicals; Skin -- Cancer -- Diagnosis -- Periodicals; Skin -- Cancer -- Prevention -- Periodicals; Skin -- Cancer -- Treatment -- Periodicals; 616.99477005
• DOI: 10.1155/2011/217378
• Languages: English
• ISSNs: 2090-2905

Abstract

Abstract : Gorlin syndrome (Naevoid Basal Cell Carcinoma Syndrome) is a rare autosomal dominant syndrome caused by mutations in the PTCH gene with a birth incidence of approximately 1 in 19, 000. Patients develop multiple basal cell carcinomas of the skin frequently in early life and also have a predisposition to additional malignancies such as medulloblastoma. Gorlin Syndrome patients also have developmental defects such as bifid ribs and other complications such as jaw keratocysts. We studied the incidence and frequency of basal cell carcinomas in 202 Gorlin syndrome patients from 62 families and compared this to their gender and mutation type. Our data suggests that the incidence of basal cell carcinomas is equal between males and females and the mutation type cannot be used to predict disease burden.